- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01669031
Randomized Controlled Trial on Visual Field Training
Effect of Exposure to Computer Simulated Visual Field Testing on Variability and Reliability of Test Results: A Randomized Controlled Trial
Study Overview
Detailed Description
3 study visits. Visit 1: Baseline visit for consent, getting baseline data and finally randomizing the patient. Those randomized to intervention get their first session of simulated visual field (2 per eye) on a regular computer for training purposes.
Visit 2: 1 to 2 days after baseline. The intervention group gets 1 practice test per eye. Then both groups get a regular automated visual field Visit 3: 1 to 2 weeks after baseline. The intervention group gets 1 practice test per eye. Then both groups get a regular automated visual field.
Study Ends, patient gets seen by the patient.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Puente Alto
-
Santiago, Puente Alto, Chile
- Recruiting
- Hospital Sotero Del Rio
-
Principal Investigator:
- Eugenio A Maul, MD MPH
-
Contact:
- Eugenio A Maul, MD/MPH
- Phone Number: +56 9 66593935
- Email: eugenio.maul@gmail.com
-
Contact:
- Militza Sanchez, CTO
- Phone Number: +56 9 73927416
- Email: militza_a@hotmail.com
-
Sub-Investigator:
- Jimena Schmidt, MD
-
Sub-Investigator:
- Andres Gerhard, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years old or greater
- Referred to the glaucoma clinic for examination due to suspected glaucoma or glaucoma diagnosis
- No more than 1 automated visual field test within the last 4 years
Exclusion Criteria:
- patients who cannot remain seated for 10 minutes
- patients with neck problems that prevent them from using the field analyzer properly
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Group
No practice tests are performed in this arm
|
|
|
Experimental: Practice Program
At the 3 study visits exposed to a training session (simulated visual field test on a computer). Visit 1 they get 2 simulated tests tests per eye. At visits 2 and 3 they get 1 simulated test per eye. Each simulated test takes 3-15 minutes |
Each practice session (simulated visual field test on computer) takes 3-15 minutes
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The absolute value of the difference in mean deviation of the first and second visual field exam
Time Frame: Visual field exams obtained 1 to 2 weeks apart
|
Visual field exams obtained 1 to 2 weeks apart
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Difference in the absolute number of altered points in the visual field with a total deviation below the 0.5 percentile
Time Frame: Visual field exams obtained 1 to 2 weeks apart
|
Visual field exams obtained 1 to 2 weeks apart
|
|
Difference in the percentage of false positives, false negatives, and fixation losses at the first and second exam between control and intervention group
Time Frame: Visual field exams obtained 1 to 2 weeks apart
|
Visual field exams obtained 1 to 2 weeks apart
|
|
Difference in the time required to complete the first and second exam
Time Frame: Visual field exams obtained 1 to 2 weeks apart
|
Visual field exams obtained 1 to 2 weeks apart
|
|
Difference in the proportion of unreliable visual fields at the first and second exam between control and intervention groups
Time Frame: Visual field exams obtained 1 to 2 weeks apart
|
Visual field exams obtained 1 to 2 weeks apart
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
- randomized controlled trial
- male
- program
- female
- aged
- reliability
- humans
- variability
- software
- prospective studies
- visual fields
- automated perimetry
- vision tests/standards
- false positive reactions
- false negative reactions
- fixation, ocular
- mean deviation
- glaucoma/diagnosis
- visual field tests/methods
- reproducibility of results
Additional Relevant MeSH Terms
Other Study ID Numbers
- Oftalmo_Glaucoma_002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glaucoma
-
Hospices Civils de LyonRecruitingOpen-angle Glaucoma | Glaucoma Eye | Pigmentary Glaucoma | Closed-Angle Glaucoma | Pseudo Exfoliative SyndromeFrance
-
Imperial College Healthcare NHS TrustIRIDEX CorporationNot yet recruitingGlaucoma | Glaucoma, Open-Angle | Glaucoma, Angle-Closure | Glaucoma, Neovascular | Glaucoma Eye | Glaucoma Secondary | Glaucoma Traumatic | Glaucoma Uveitic
-
Wills EyeIOP OphthalmicsTerminatedPrimary Open Angle Glaucoma | Neovascular Glaucoma | Uveitic Glaucoma | Pseudoexfoliation Glaucoma | Primary Angle Closure Glaucoma | Pigmentary Glaucoma | Traumatic GlaucomaUnited States
-
University of MiamiAbbVieRecruitingOcular Hypertension | Glaucoma | Open-Angle Glaucoma | Glaucoma SuspectUnited States
-
Ngoc Nguyen Inc.Alcon ResearchNot yet recruitingGlaucoma | Glaucoma, Open Angle | Open Angle Glaucoma (OAG) | Normal Tension Glaucoma (NTG)United States
-
Isfahan University of Medical SciencesActive, not recruitingAngle Closure Glaucoma | Glaucoma EyeIran
-
Centre hospitalier de l'Université de Montréal...CompletedGlaucoma | Glaucoma, Open-Angle | Glaucoma, Neovascular | Glaucoma Eye | Glaucoma and Ocular Hypertension | Glaucoma, Uncompensated | Glaucoma SecondaryCanada
-
Pro Top & Mediking Company LimitedCompletedOpen Angle Glaucoma | Neovascular Glaucoma | Angle Closure Glaucoma | Uveitis Glaucoma | Young Age Glaucoma | High Risk PatientEstonia
-
Henry Ford Health SystemNot yet recruitingPrimary Open Angle Glaucoma (POAG) | Secondary Open Angle Glaucoma | Open Angle Glaucoma (OAG)United States
-
Sanoculis LtdCompletedPrimary Open Angle Glaucoma | Pigmentary Glaucoma | Pseudoexfoliative GlaucomaIsrael
Clinical Trials on Practice program
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedUrinary IncontinenceUnited States
-
Virginia Polytechnic Institute and State UniversityRecruitingAlzheimer Disease | AgingUnited States
-
Hopital FochCompleted
-
Bianca HornerUniversity of CalgaryTerminatedDepression, Anxiety DisordersCanada
-
University of Massachusetts, WorcesterHarvard School of Public Health (HSPH)CompletedPediatric ObesityUnited States
-
Cintia Silva FassarellaUniversidade do Porto; CINTESIS - Center for Health Technology and Services...Active, not recruitingPrimary Health Care | Patient Safety | Healthy Work EnvironmentPortugal
-
Indiana UniversityNational Institute of Mental Health (NIMH); University of Florida; Eskenazi HealthCompletedMental Illness | Shared Decision MakingUnited States
-
Instituto de Salud Carlos IIIFondo de Investigacion Sanitaria; Osakidetza; MurciaSaludCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted